Article Details

Rocket Pharmaceuticals' (RCKT) "Buy" Rating Reiterated at Chardan Capital | MarketBeat

Retrieved on: 2021-09-08 01:07:30

Tags for this article:

Click the tags to see associated articles and topics

Rocket Pharmaceuticals' (RCKT) "Buy" Rating Reiterated at Chardan Capital | MarketBeat. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 3,207,765 shares of the biotechnology company's stock valued at $142,072,000 after buying an additional 296,191 shares during the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up